0001864104-25-000002.txt : 20250818 0001864104-25-000002.hdr.sgml : 20250818 20250818171438 ACCESSION NUMBER: 0001864104-25-000002 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering FILED AS OF DATE: 20250818 DATE AS OF CHANGE: 20250818 EFFECTIVENESS DATE: 20250818 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Protibea Therapeutics, Inc. CENTRAL INDEX KEY: 0001864104 ORGANIZATION NAME: EIN: 863104099 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-555107 FILM NUMBER: 251228823 BUSINESS ADDRESS: STREET 1: 1108 LEGACY CROSSING CITY: GEORGETOWN STATE: TX ZIP: 78628 BUSINESS PHONE: 216-297-4167 MAIL ADDRESS: STREET 1: 1108 LEGACY CROSSING CITY: GEORGETOWN STATE: TX ZIP: 78628 D 1 primary_doc.xml X0708 D LIVE 0001864104 Protibea Therapeutics, Inc. 1108 LEGACY CROSSING GEORGETOWN TX TEXAS 78628 915-490-0715 DELAWARE None None Corporation true 2021 William Chamberlin 1108 Legacy Crossing Georgetown TX TEXAS 78628 Executive Officer Director CEO of the Issuer Jim Moriarty 1108 Legacy Crossing Georgetown TX TEXAS 78628 Executive Officer Director Yu Ge 1108 Legacy Crossing Georgetown TX TEXAS 78628 Director Harry Oken 1108 Legacy Georgetown TX TEXAS 78628 Director Other Health Care Decline to Disclose 06b false 2025-07-30 true true true Right to acquire another security false 100000 11700000 200000 11500000 false 2 0 0 0 false Protibea Therapeutics, Inc. /s/ William M. Chamberlin, MD William M. Chamberlin, MD CEO of the Issuer 2025-08-18